“…These enzymes possess potential efficacy for health augmentation and nutraceutical use, and their application could prevent cardiovascular diseases effectively [28]. Marine microorganisms producing fibrinolytic enzymes, including bacteria (Streptomyces lusitanus [43], Streptomyces radiopugnans VITSD8 [44], Streptomyces violaceus VI-TYGM [45], Pseudomonas aeruginosa KU1 [46,47], Alteromonas piscicida [48], Pseudoalteromonas sp. IND11 [49], bacterial strain GPJ3 [50], Marinobacter aquaeolei MS2-1 [51], Bacillus flexus [52], Bacillus subtilis [53], Bacillus subtilis HQS-3 [54], Bacillus vallismortis [55], Bacillus subtilis D21-8 [56], Bacillus pumilus BS15 [29], Bacillus subtilis WR350 [57], Bacillus subtilis JS2 [58], Bacillus velezensis BS2 [59], Bacillus subtilis ICTF-1 [41], Shewanella sp.…”